Improving vaccines by incorporating immunological coadjuvants

被引：64

作者：

Fraser, Cara K. ^{[1
]}

Diener, Kerrilyn R. ^{[1
]}

Brown, Michael P. ^{[1
]}

Hayball, John D. ^{[1
]}

机构：

[1] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5000, Australia

来源：

EXPERT REVIEW OF VACCINES | 2007年 / 6卷 / 04期

关键词：

adjuvants; coadjuvants; infectious disease; vaccine's;

D O I：

10.1586/14760584.6.4.559

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

While vaccination continues to be the most successful interventionist health policy to date, infectious disease remains a significant cause of death worldwide. A primary reason that vaccination is not able to generate effective immunity is a lack of appropriate adjuvants capable of initiating the desired immune response. Adjuvant combinations can potentially overcome this problem; however, the possible permutations to consider, which include the route and kinetics of vaccination, as well as combinations of adjuvants, are practically limitless. This review aims to summarize the current understanding of adjuvants and related immunological processes and how this knowledge can and has been applied to the strategic selection of adjuvant combinations as components of vaccines against human infectious disease.

引用

页码：559 / 578

页数：20

共 184 条

[1] Improving recombinant MVA immune responses:: Potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma [J].

Abaitua, F ;

Rodríguez, JR ;

Garzón, A ;

Rodríguez, D ;

Esteban, M .

VIRUS RESEARCH, 2006, 116 (1-2) :11-20

[2] Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31 [J].

Agger, Else Marie ;

Rosenkrands, Ida ;

Olsen, Anja Weinreich ;

Hatch, Graham ;

Williams, Ann ;

Kritsch, Constantia ;

Lingnau, Karen ;

von Gabain, Alexander ;

Andersen, Claire Swetman ;

Korsholm, Karen Smith ;

Andersen, Peter .

VACCINE, 2006, 24 (26) :5452-5460

[3] NALP3 forms an IL-lβ-Processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder [J].

Agostini, L ;

Martinon, F ;

Burns, K ;

McDermott, MF ;

Hawkins, PN ;

Tschopp, J .

IMMUNITY, 2004, 20 (03) :319-325

[4] The ADP-ribosylating CTA1-DD adjuvant enhances T cell-dependent and independent responses by direct action on B cells involving anti-apoptotic bcl-2-and germinal center-promoting effects [J].

Ågren, L ;

Sverremark, E ;

Ekman, L ;

Schön, K ;

Löwenadler, B ;

Fernandez, C ;

Lycke, N .

JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6276-6286

[5] Cytokine, chemokine, and costimulatory molecule modulation to enhance efficacy of HIV vaccines [J].

Ahlers, JD ;

Belyakov, IM ;

Berzofsky, JA .

CURRENT MOLECULAR MEDICINE, 2003, 3 (03) :285-301

[6] A push-pull approach to maximize vaccine efficacy: Abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L [J].

Ahlers, JD ;

Belyakov, IM ;

Terabe, M ;

Koka, R ;

Donaldson, DD ;

Thomas, EK ;

Berzofsky, JA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) :13020-13025

[7] Signals delivered through TCR instruct IL-12 receptor (IL-12R) expression:: IL-12 and tumor necrosis factor-α synergize for IL-12R expression at low antigen dose [J].

Ahlers, JD ;

Belyakov, IM ;

Matsui, S ;

Berzofsky, JA .

INTERNATIONAL IMMUNOLOGY, 2001, 13 (11) :1433-1442

[8] Mechanisms of cytokine synergy essential for vaccine protection against viral challenge [J].

Ahlers, JD ;

Belyakov, IM ;

Matsui, S ;

Berzofsky, JA .

INTERNATIONAL IMMUNOLOGY, 2001, 13 (07) :897-908

[9] Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN [J].

Ahonen, CL ;

Doxsee, CL ;

McGurran, SM ;

Riter, TR ;

Wade, WF ;

Barth, RJ ;

Vasilakos, JP ;

Noelle, RJ ;

Kedl, RM .

JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (06) :775-784

[10] Pathogen recognition and innate immunity [J].

Akira, S ;

Uematsu, S ;

Takeuchi, O .

CELL, 2006, 124 (04) :783-801

← 1 2 3 4 5 6 7 8 9 10 →